ClearPoint Neuro, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q2 2024 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q3 2024 | 2 | -$0.19 | -$0.14 | -$0.17 |
Q4 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q1 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q2 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
Q3 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q4 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
ClearPoint Neuro, Inc. Earnings Date And Information
ClearPoint Neuro, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.18 earnings per share for the quarter, missing analysts' consensus estimates of $-0.17 by $0.01. The company had revenue of 8.12 M for the quarter and had revenue of 23.96 M for the year. ClearPoint Neuro, Inc. has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -17.71. ClearPoint Neuro, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
ClearPoint Neuro, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.17 | -$0.18 | -0.01 | $7.77 M | $8.12 M |
08/07/2024 | Q2 2024 | -$0.19 | -$0.16 | 0.03 | $7.33 M | $7.86 M |
05/07/2024 | Q1 2024 | -$0.19 | -$0.16 | 0.03 | $7.64 M | |
03/12/2024 | Q4 2023 | -$0.22 | -$0.19 | 0.03 | $6.81 M | |
11/09/2023 | Q3 2023 | -$0.25 | -$0.20 | 0.05 | $6.73 M | $5.76 M |
08/08/2023 | Q2 2023 | -$0.18 | -$0.29 | -0.11 | $5.90 M | $5.95 M |
05/11/2023 | Q1 2023 | -$0.18 | -$0.22 | -0.04 | $5.43 M | |
03/01/2023 | Q4 2022 | -$0.22 | -$0.18 | 0.04 | $5.17 M | |
11/08/2022 | Q3 2022 | -$0.19 | -$0.15 | 0.04 | $5.40 M | $5.15 M |
08/09/2022 | Q2 2022 | -$0.18 | $5.08 M | $5.20 M | ||
05/11/2022 | Q1 2022 | -$0.20 | -$0.17 | 0.03 | $5.03 M | |
03/08/2022 | Q4 2021 | -$0.18 | $4.28 M | |||
11/09/2021 | Q3 2021 | -$0.18 | $4.00 M | $4.57 M | ||
08/12/2021 | Q2 2021 | -$0.17 | $3.69 M | $3.41 M | ||
05/11/2021 | Q1 2021 | -$0.15 | -$0.13 | 0.02 | $4.03 M | |
03/22/2021 | Q4 2020 | -$0.09 | $3.72 M | |||
11/12/2020 | Q3 2020 | -$0.09 | $2.47 M | $3.52 M | ||
08/13/2020 | Q2 2020 | -$0.11 | $1.88 M | $2.48 M | ||
05/13/2020 | Q1 2020 | -$0.13 | $3.12 M | |||
03/27/2020 | Q4 2019 | -$0.11 | $3.21 M |
ClearPoint Neuro, Inc. Earnings: Frequently Asked Questions
-
When is ClearPoint Neuro, Inc.'s earnings date?
ClearPoint Neuro, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to ClearPoint Neuro, Inc.'s earnings conference call?
The conference call for ClearPoint Neuro, Inc.'s latest earnings report can be listened to online.
-
How can I read ClearPoint Neuro, Inc.'s conference call transcript?
The conference call transcript for ClearPoint Neuro, Inc.'s latest earnings report can be read online.
-
How much revenue does ClearPoint Neuro, Inc. generate each year?
ClearPoint Neuro, Inc. (:CLPT) has a recorded annual revenue of $23.96 M.
-
How much profit does ClearPoint Neuro, Inc. generate each year?
ClearPoint Neuro, Inc. (:CLPT) has a recorded net income of $23.96 M. ClearPoint Neuro, Inc. has generated $-0.9 earnings per share over the last four quarters.
-
What is ClearPoint Neuro, Inc.'s price-to-earnings ratio?
ClearPoint Neuro, Inc. (:CLPT) has a price-to-earnings ratio of -17.71 and price/earnings-to-growth ratio is -1.14.